| PERIOD ENDING | 25-Apr-09 | 24-Jan-09 | 25-Oct-08 | 26-Jul-08 | | Total Revenue | 779,884 | 811,023 | 759,461 | 743,859 | | Cost of Revenue | 510,774 | 541,914 | 505,886 | 492,129 | | | Gross Profit | 269,110 | 269,109 | 253,575 | 251,730 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 176,622 | 177,567 | 170,973 | 172,136 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 92,488 | 91,542 | 82,602 | 79,594 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 510 | 255 | 669 | 2,140 | | Earnings Before Interest And Taxes | 92,998 | 91,797 | 83,271 | 81,734 | | Interest Expense | 6,914 | 7,000 | 8,183 | 8,052 | | Income Before Tax | 86,084 | 84,797 | 75,088 | 73,682 | | Income Tax Expense | 32,123 | 31,990 | 28,185 | 27,718 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 53,961 | 52,807 | 46,903 | 45,964 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 53,961 | 52,807 | 46,903 | 45,964 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $53,961 | $52,807 | $46,903 | $45,964 |
|
0.45% Nasdaq 
0.20%
Income Statement
